Mental health across two years of the COVID-19 pandemic: a 5-wave longitudinal study in Germany
Frontiers in Psychiatry · 08.08.2023 · 14
DOI: 10.3389/fpsyt.2023.1229700 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Psychiatry, online erschienen am 08.08.2023. Verfasst von Maxi Weber und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Education and Psychology, Clinical Psychology and Psychotherapy, Freie Universität Berlin, Berlin, Germany. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The COVID-19 pandemic has been negatively associated with mental health. However, little is known about the temporal dynamics of mental health in the longer term of the pandemic. We aimed to investigate symptom levels and changes of depression, anxiety, posttraumatic stress, and loneliness spanning two years of the pandemic; and to examine associated risk factors. This five-wave, longitudinal online study from May 2020 to April 2022 included 636 adults (M age = 39.5 years, SD = 16.11; 84.1% female) from the German general population who completed the international COVID-19 Mental Health Survey. Symptoms of anxiety (Generalized Anxiety Disorder-7; GAD-7), depression (Patient Health Questionnaire-9; PHQ-9), posttraumatic stress (PTSD Checklist for DSM-5; PCL-5), and loneliness (“ Do you feel lonely?” ) were assessed using mixed-effects models. Associations with anxiety and depressive symptoms were examined with having children, student status, financial worries, contamination fear, and loneliness. PHQ-9, GAD-7, PCL-5, and loneliness scores overall decreased throughout the two-year period of the pandemic but exhibited an increase during two national lockdowns. Controlled for significant associations with female gender and younger age, increased PHQ-9 and GAD-7 scores were associated with contamination fear, financial worries, and loneliness. No associations were found with having children and student status. Symptoms of depression, anxiety, posttraumatic stress, and loneliness decreased over time but varied along with the dynamics of the pandemic. Longitudinal monitoring of mental health in vulnerable subgroups is required, especially those of younger age, females, and the financially insecure.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Education and Psychology, Clinical Psychology and Psychotherapy, Freie Universität Berlin, Berlin, Germany.
- Department of Education and Psychology, Clinical Psychological Intervention, Freie Universität Berlin, Berlin, Germany.
- Department of Clinical, Neuro-, and Developmental Psychology, Amsterdam Public Health Institute and WHO Collaborating Center for Research and Dissemination of Psychological Interventions, Vrije Universiteit, Amsterdam,…
- Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
- Clinical Psychology and Psychotherapy, Institute for Mental Health and Behavioral Medicine, HMU Health and Medical University, Potsdam, Germany.
Zitieren
APA
Weber, M., Burchert, S., Sijbrandij, M., Patanè, M., Pinucci, I., Renneberg, B., Knaevelsrud, C., & Schumacher, S. (2023). Mental health across two years of the COVID-19 pandemic: a 5-wave longitudinal study in Germany. Frontiers in Psychiatry, 14. https://doi.org/10.3389/fpsyt.2023.1229700
Vancouver
Weber M, Burchert S, Sijbrandij M, Patanè M, Pinucci I, Renneberg B, et al. Mental health across two years of the COVID-19 pandemic: a 5-wave longitudinal study in Germany. Frontiers in Psychiatry. 2023;14. doi:10.3389/fpsyt.2023.1229700
BibTeX
@article{Weber2023,
author = {Weber, Maxi and Burchert, Sebastian and Sijbrandij, Marit and Patanè, Martina and Pinucci, Irene and Renneberg, Babette and Knaevelsrud, Christine and Schumacher, Sarah},
title = {Mental health across two years of the COVID-19 pandemic: a 5-wave longitudinal study in Germany},
journal = {Frontiers in Psychiatry},
year = {2023},
volume = {14},
doi = {10.3389/fpsyt.2023.1229700}
}
EUVIMED